AR081150A1 - THE APPLICATION OF BACTERIA OF THE LACTIC ACID FOR THE TREATMENT OR PREVENTION OF RHINITIS - Google Patents

THE APPLICATION OF BACTERIA OF THE LACTIC ACID FOR THE TREATMENT OR PREVENTION OF RHINITIS

Info

Publication number
AR081150A1
AR081150A1 ARP110100460A ARP110100460A AR081150A1 AR 081150 A1 AR081150 A1 AR 081150A1 AR P110100460 A ARP110100460 A AR P110100460A AR P110100460 A ARP110100460 A AR P110100460A AR 081150 A1 AR081150 A1 AR 081150A1
Authority
AR
Argentina
Prior art keywords
lactobacillus rhamnosus
rhinitis
formula
prevention
treatment
Prior art date
Application number
ARP110100460A
Other languages
Spanish (es)
Original Assignee
Salmon Bernadette
Wickens Kristin Lee
Stanley Thorstem Villiers
Fitzharris Penelope Frances
Crane Julian
Mitchell Edwin Arthur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salmon Bernadette, Wickens Kristin Lee, Stanley Thorstem Villiers, Fitzharris Penelope Frances, Crane Julian, Mitchell Edwin Arthur filed Critical Salmon Bernadette
Publication of AR081150A1 publication Critical patent/AR081150A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El uso de la Lactobacillus rhamnosus HN001 o de sus derivados para el tratamiento o la prevención de la rinitis. Reivindicación 1: Un método para tratar o prevenir la rinitis en un sujeto, caracterizado porque incluye administrar Lactobacillus rhamnosus HN001 o un derivado de la misma a un sujeto que la necesite. Reivindicación 4: El método de cualquiera de las reivindicaciones 1 a 3, caracterizado porque el Lactobacillus rhamnosus HN001 o su derivado se administra en una composición que incluye un diluyente, adyuvante, vehículo o excipiente fisiológicamente aceptable. Reivindicación 5: El método de la reivindicación 4, caracterizado porque la composición incluye una fórmula para lactante, una fórmula de seguimiento, una fórmula de crecimiento, una fórmula maternal, un complemento maternal, un producto dietético, o un alimento. Reivindicación 32: El Lactobacillus rhamnosus HN001 de cualquiera de las reivindicaciones 29 a 31, caracterizado porque el Lactobacillus rhamnosus HN001 o su derivado o composición es para la administración oral a una madre embarazada durante la gestación o a una madre que amamanta.The use of Lactobacillus rhamnosus HN001 or its derivatives for the treatment or prevention of rhinitis. Claim 1: A method for treating or preventing rhinitis in a subject, characterized in that it includes administering Lactobacillus rhamnosus HN001 or a derivative thereof to a subject in need. Claim 4: The method of any one of claims 1 to 3, characterized in that Lactobacillus rhamnosus HN001 or its derivative is administered in a composition that includes a physiologically acceptable diluent, adjuvant, vehicle or excipient. Claim 5: The method of claim 4, characterized in that the composition includes a infant formula, a follow-up formula, a growth formula, a maternal formula, a maternal supplement, a dietary product, or a food. Claim 32: The Lactobacillus rhamnosus HN001 of any one of claims 29 to 31, characterized in that the Lactobacillus rhamnosus HN001 or its derivative or composition is for oral administration to a pregnant mother during pregnancy or to a breastfeeding mother.

ARP110100460A 2010-02-15 2011-02-15 THE APPLICATION OF BACTERIA OF THE LACTIC ACID FOR THE TREATMENT OR PREVENTION OF RHINITIS AR081150A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ58329810 2010-02-15

Publications (1)

Publication Number Publication Date
AR081150A1 true AR081150A1 (en) 2012-07-04

Family

ID=44367953

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100460A AR081150A1 (en) 2010-02-15 2011-02-15 THE APPLICATION OF BACTERIA OF THE LACTIC ACID FOR THE TREATMENT OR PREVENTION OF RHINITIS

Country Status (3)

Country Link
AR (1) AR081150A1 (en)
TW (1) TW201201820A (en)
WO (1) WO2011099875A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744778C (en) 2008-11-28 2019-01-15 University Of Otago Use of lactic acid bacteria to treat or prevent eczema
WO2018162619A1 (en) 2017-03-08 2018-09-13 N.V. Nutricia Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation
CN111139204B (en) * 2020-01-21 2023-04-14 上海城建职业学院 Probiotic bacteria agent and preparation method and application thereof
CN113785985A (en) * 2021-09-18 2021-12-14 中盐工程技术研究院有限公司 Probiotic composition, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8455801A (en) * 2000-08-08 2002-02-18 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
WO2005056801A1 (en) * 2003-12-15 2005-06-23 Genesis Research And Development Corporation Limited Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
CA2744778C (en) * 2008-11-28 2019-01-15 University Of Otago Use of lactic acid bacteria to treat or prevent eczema

Also Published As

Publication number Publication date
TW201201820A (en) 2012-01-16
WO2011099875A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
CL2017000830A1 (en) Stable formulation comprising a non-reducing sugar, an anti-s4b7 antibody and at least one free amino acid; a method for preparing said formulation; use of said formulation to treat an inflammatory bowel disease.
PH12020550069A1 (en) Process for purifying sialylated oligosaccharides
CY1117183T1 (en) BRANCHED 3-PHENYLOPROPIONIC ACID PRODUCTS AND THEIR USE
MX2014004719A (en) Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery.
EA201390305A1 (en) COMPOSITIONS FOR MOISTURAL AND ORAL INTAKE OF LACTOBACILLUS AND THEIR APPLICATION
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
BR112015000136A2 (en) dietary fiber for use in treating a gastrointestinal side effect of a nutrition or medicine
WO2015177246A8 (en) Neonatal microbiome supplementation
AR081150A1 (en) THE APPLICATION OF BACTERIA OF THE LACTIC ACID FOR THE TREATMENT OR PREVENTION OF RHINITIS
RU2014106509A (en) OBTAINING AND USE OF BACTERIAL HISTAMINE
NZ594184A (en) Skin treatment
BR112015028164A2 (en) probiotics and methods of use
PH12015502517B1 (en) Compositions and methods for nutrient delivery
EP2575456A4 (en) Compositions and methods for treating bruises
BR112013026644A2 (en) method for modulating cytokine activity
MY173927A (en) Formula fortifier
HRP20230639T1 (en) Preparation comprising lactobacillus reuteri and citrate for medical use
MX342798B (en) Novel compound and medical use thereof.
MX355787B (en) Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom.
PE20130308A1 (en) METHODS TO TREAT RECURRING BACTERIAL INFECTIONS
RU2013133998A (en) METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEOARTHRITIS
MY169302A (en) Compositions and methods for nutrient delivery
NZ613264A (en) Use of vitamin k for weight maintenance and weight control
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders

Legal Events

Date Code Title Description
FB Suspension of granting procedure